{site-name}

WHY WAISMAN?

The primary mission of  Waisman Biomanufacturing is to provide cGMP manufacturing services to serve researchers, clinicians and business ventures in the development of novel biological therapies for clinical trials.  

Waisman has a proven track record of success in making clinical trial material for universities, the National Institutes of Health (NIH), as well as both small and large companies nationally and internationally. Since opening its cGMP facility in 2001, Waisman Biomanufacturing has manufactured over 300 clinical grade products and has earned a reputation for working closely with clients for cost effective and timely manufacture of quality products.  We strive to meet these high standards with each product campaign.

Read more